Nuvectis Pharma Launches $100 Million Share Offering Amid Stock Decline

Nuvectis Pharma has initiated a $100 million share offering, which has coincided with a drop in its stock value. This capital raise may be critical for the company's financial health, but the stock's decline raises concerns about investor confidence and market perception.